{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:43Z","timestamp":1792785943547,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Morris K Udall Centre of Excellence in Parkinson's disease research at UCLA","award":["P50 NS38367"],"award-info":[{"award-number":["P50 NS38367"]}]},{"name":"Centre for Gene Environment in Parkinson's disease","award":["P01 ES016732"],"award-info":[{"award-number":["P01 ES016732"]}]},{"name":"American Parkinson Disease Association Advances Centre at UCLA","id":[{"id":"https:\/\/ror.org\/04sedwh45","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Center for the Study of Parkinson's Disease at UCLA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.expneurol.2012.06.025","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T12:03:05Z","timestamp":1340798585000},"page":"318-334","source":"Crossref","is-referenced-by-count":234,"title":["Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein"],"prefix":"10.1016","volume":"237","author":[{"given":"Melanie B.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauryn","family":"Gabby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita B.","family":"Effros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Chesselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.06.025_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","article-title":"T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis, are we listening?","volume":"31","author":"Appel","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0020","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/mds.21552","article-title":"Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET","volume":"22","author":"Bartels","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0025","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","article-title":"Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor","volume":"19","author":"Batchelor","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2011.00080","article-title":"Alpha-synuclein alters toll-like receptor expression","volume":"5","author":"Beraud","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0040","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0055","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0060","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modeling of Parkinson's disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2006.07.031","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1\u201342 in the rat hippocampus in vivo","volume":"52","author":"Clarke","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0070","first-page":"RA165","article-title":"Immune processes in the pathogenesis of Parkinson's disease \u2014 a potential role for microglia and nitric oxide","volume":"8","author":"Czlonkowska","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0080","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0085","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.253.5018.390","article-title":"Statistical data analysis in the computer age","volume":"253","author":"Efron","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0090","doi-asserted-by":"crossref","first-page":"e22225","DOI":"10.1371\/journal.pone.0022225","article-title":"Assessment of alpha-synuclein secretion in mouse and human brain parenchyma","volume":"6","author":"Emmanouilidou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0095","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008877-200609000-00004","article-title":"Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism","volume":"17","author":"Fleming","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0115","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0120","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","article-title":"Neural activity controls the synaptic accumulation of alpha-synuclein","volume":"25","author":"Fortin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0125","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson's disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2012.06.025_bb1111","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.20102","article-title":"Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease","volume":"55","author":"Lang","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0165","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0170","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0175","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neurobiolaging.2007.08.018","article-title":"Screening of innate immune receptors in neurodegenerative diseases: a similar pattern","volume":"30","author":"Letiembre","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0180","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/mt.2008.146","article-title":"Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats","volume":"16","author":"McCoy","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0185","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0200","first-page":"135","article-title":"Neurotrophins and cytokines in Parkinson's disease","volume":"80","author":"Mogi","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02252965","article-title":"Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease","volume":"9","author":"Mogi","year":"1995","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0205","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson's disease","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0210","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","article-title":"Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs","volume":"173","author":"Olson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.expneurol.2012.06.025_bb0215","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","article-title":"Neuroinflammation in the living brain of Parkinson's disease","volume":"15","author":"Ouchi","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0225","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2012.06.025_bb0230","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1002\/mds.22638","article-title":"Inflammation and Parkinson's disease pathogenesis","volume":"25","author":"Przedborski","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainres.2006.03.040","article-title":"P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain","volume":"1089","author":"Rappold","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson's disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0245","first-page":"195","article-title":"Replication of GWAS associations for GAK and MAPT in Parkinson's disease","volume":"75","author":"Rhodes","year":"2011","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0250","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0255","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/mds.23274","article-title":"Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study","volume":"25","author":"Rugbjerg","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0260","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","article-title":"Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance","volume":"468","author":"Scalzo","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0275","article-title":"Pathological neuron\u2013glia interaction through extracellular alpha-synuclein","author":"Lee","year":"2011"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0290","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0285","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0295","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1189\/jlb.0608385","article-title":"Microglia: gatekeepers of central nervous system immunology","volume":"85","author":"Tambuyzer","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0300","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0305","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb07468.x","article-title":"Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses","volume":"991","author":"Trojanowski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0315","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","article-title":"Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease","volume":"69","author":"Wahner","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2012.06.025_bb0320","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.64.6.836","article-title":"Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease","volume":"64","author":"Wahner","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0325","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/jnr.22327","article-title":"Alpha synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway","volume":"88","author":"Wu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.06.025_bb0330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612002671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612002671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:24:21Z","timestamp":1714091061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612002671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0014488612002671"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.025","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}